2-Piperidinobenzonitrile

Catalog No.: 
ACTGLS540
CAS No.: 
72752-52-4
Molecular Formula: 
C12H14N2
Molecular Weight: 
186.26
2-Piperidinobenzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$95.00InquiryInquiry
100g98%$273.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Piperidinobenzonitrile
IUPAC Name2-(piperidin-1-yl)benzonitrile
MDL No.MFCD00049221
Molecular FormulaC12H14N2
Molecular Weight186.26
SMILESN#CC1=C(C=CC=C1)N1CCCCC1
InChI KeyMEBVSLLKZSAIGK-UHFFFAOYSA-N
Synonym2-PIPERIDINOBENZENECARBONITRILE;2-PIPERIDINOBENZONITRILE;2-(1-PIPERIDINO)BENZONITRILE;BUTTPARK 33\12-73;2-(1-PIPERIDINE)BENZONITRILE;2-(1-Piperidinyl)benzonitrile, 97%;1-(2-cyanophenyl)piperidine;2-Piperidinobenzonitrile 97%
CAS No.72752-52-4
PubChem CID2774355

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTGLS540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFCL270 route compound structure diagram
    ACUFCL270111-24-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGLS540 route product structure diagram
    ACTGLS54072752-52-4
Inquiry

2. ACTGLS540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGLS540 route product structure diagram
    ACTGLS54072752-52-4
Inquiry

3. ACTGLS540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGLS540 route product structure diagram
    ACTGLS54072752-52-4
Inquiry

Comments (0)